S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:MRAI

Marpai (MRAI) Stock Price, News & Analysis

$2.44
+0.36 (+17.31%)
(As of 03/28/2024 ET)
Today's Range
$2.18
$2.72
50-Day Range
$1.12
$2.66
52-Week Range
$0.33
$13.60
Volume
681,022 shs
Average Volume
1.00 million shs
Market Capitalization
$25.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Marpai MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
145.9% Upside
$6.00 Price Target
Short Interest
Bearish
8.02% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.85mentions of Marpai in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$2.52 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.91 out of 5 stars

Business Services Sector

162nd out of 310 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

4th out of 5 stocks

MRAI stock logo

About Marpai Stock (NASDAQ:MRAI)

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.

MRAI Stock Price History

MRAI Stock News Headlines

Marpai (NASDAQ:MRAI) Lifted to Buy at Maxim Group
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Q4 2023 Marpai Inc Earnings Call
Marpai (MRAI) Scheduled to Post Earnings on Tuesday
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
MARPAI ANNOUNCES "OFF-CYCLE" NEW CLIENT AGREEMENT
Marpai Adjusts AXA Deal Terms, Sells Future Receipts
MARPAI ANNOUNCES KEY FINANCIAL AGREEMENTS
Marpai CEO & Director Acquires 84% More Stock
Why Is Marpai (MRAI) Stock Up 27% Today?
Marpai appoints John Powers as its CEO
MARPAI HIRES JOHN POWERS AS PRESIDENT
Marpai Inc Class A
CEO & Director of Marpai Picks Up 29% More Stock
MARPAI TO HOST INVESTOR WEBCAST ON NOVEMBER 29, 2023
Marpai Inc - Ordinary Shares Class A
MARPAI, INC. REPORTS THIRD QUARTER 2023 RESULTS
See More Headlines
Receive MRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/26/2024
Today
3/28/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MRAI
Fax
N/A
Employees
303
Year Founded
N/A

Profitability

Net Income
$-26,470,000.00
Pretax Margin
-90.86%

Debt

Sales & Book Value

Annual Sales
$37.15 million
Book Value
$1.15 per share

Miscellaneous

Free Float
3,974,000
Market Cap
$25.06 million
Optionable
No Data
Beta
5.25
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Damien Francis Lamendola (Age 67)
    CEO & Director
  • Mr. Steve Johnson (Age 53)
    CFO & Company Secretary
  • Mr. Yaron I. Eitan (Age 68)
    Co-Founder & Chairman of the Board
  • Mr. John Powers (Age 56)
    President & COO
  • Dr. Eli David (Age 42)
    Co-Founder & Chief Science Advisor
  • Ms. Pamela Burns
    Vice President of Enterprise Sales
  • Simon Li
    Vice President

MRAI Stock Analysis - Frequently Asked Questions

Should I buy or sell Marpai stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marpai in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MRAI shares.
View MRAI analyst ratings
or view top-rated stocks.

What is Marpai's stock price target for 2024?

1 brokers have issued 1-year target prices for Marpai's stock. Their MRAI share price targets range from $6.00 to $6.00. On average, they predict the company's share price to reach $6.00 in the next year. This suggests a possible upside of 145.9% from the stock's current price.
View analysts price targets for MRAI
or view top-rated stocks among Wall Street analysts.

How have MRAI shares performed in 2024?

Marpai's stock was trading at $1.75 at the beginning of the year. Since then, MRAI shares have increased by 39.4% and is now trading at $2.44.
View the best growth stocks for 2024 here
.

Are investors shorting Marpai?

Marpai saw a increase in short interest in March. As of March 15th, there was short interest totaling 212,500 shares, an increase of 419.6% from the February 29th total of 40,900 shares. Based on an average daily volume of 813,600 shares, the days-to-cover ratio is currently 0.3 days. Currently, 8.0% of the company's stock are short sold.
View Marpai's Short Interest
.

When is Marpai's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our MRAI earnings forecast
.

How were Marpai's earnings last quarter?

Marpai, Inc. (NASDAQ:MRAI) issued its quarterly earnings data on Tuesday, March, 26th. The company reported ($0.65) earnings per share (EPS) for the quarter. The firm had revenue of $8.71 million for the quarter. Marpai had a negative net margin of 77.38% and a negative trailing twelve-month return on equity of 789.96%.

When did Marpai's stock split?

Shares of Marpai reverse split on Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What guidance has Marpai issued on next quarter's earnings?

Marpai updated its FY 2023 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $37.2 million-$37.2 million, compared to the consensus revenue estimate of $34.6 million.

When did Marpai IPO?

Marpai (MRAI) raised $25 million in an initial public offering on Wednesday, October 27th 2021. The company issued 6,300,000 shares at a price of $4.00 per share. ThinkEquity served as the underwriter for the IPO.

Who are Marpai's major shareholders?

Marpai's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.24%) and Vanguard Group Inc. (1.24%). Insiders that own company stock include Damien Lamendola, Edmundo Gonzalez, Jane Cavalier, Robert M Pons, Ronnie Brown, Vincent Kane, Yaron Eitan and Yoram Bibring.
View institutional ownership trends
.

How do I buy shares of Marpai?

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MRAI) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners